Platinum Group Metals Ltd (AMEX:PLG) reported that its development plans for the 74% owned Western Bushveld Joint Venture (”WBJV”) Project 1 Platinum Mine are advancing on budget and within three weeks of project schedule. Construction work of approximately 30,000 man-hours, including roads, box cut excavation for the declines and site infrastructure has progressed safely with no loss time incidents.

Platinum Group Metals Ltd. engages in the exploration and development of mineral properties in Canada and South Africa.

*********************************************

PharmAthene, Inc. (AMEX:PIP) announced that the Company was added to the Russell Global Index and the Russell 3000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 24, 2011. The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization. The new membership lists are available at http://www.russell.com/indexes/tools-resources/reconstitution.asp. Membership in the Russell Global Index, which remains in place for one year, means automatic inclusion in the appropriate large-cap, small-cap, all-cap indexes as well as the applicable style, sector and country indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

PharmAthene, Inc., a biodefense company, together with its subsidiaries, engages in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

*********************************************

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:

Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

Breasts are made up of fat, connective tissue and gland tissue divided into lobes. The lobes are connected to your nipple by ducts.
Most women have breasts of different sizes which look and feel different at certain times of the month, depending on their menstrual cycle. Your breasts also change during the different stages of your life, for example, after menopause, they become less full or dense.
Breast tissue goes into your armpit where there are lymph nodes. These are glands that are part of your immune system.
Breast cancer usually starts in the cells lining the ends of the lobes and in the ducts themselves. It can spread from there into the breast tissue and lymph nodes.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

*********************************************

Vista Gold Corp. (AMEX:VGZ) is pleased to announce the initial results of drilling completed at the Batman deposit during the 2010-11 program at the Mt. Todd gold project in Northern Territory, Australia. Vista is undertaking a bankable feasibility study (”BFS”) for the Mt. Todd gold project which it expects to complete late this year. In support of the BFS, the Company started drilling at the Batman deposit in 2010 and the program is ongoing at the time of this announcement. This press release contains the results of gold assays of samples taken from 10 core holes (5740 total meters drilled) from the first phase of the program.

Vista Gold Corp. and its subsidiaries engage in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.

*********************************************

New Energy Systems Group (AMEX:NEWN) announced that it has been added to the Russell Microcap Index effective June 24, 2011. Russell Investments, a leading financial services provider serving individual and institutional investors, rebalances its entire family of indexes every year to maintain true representation of global equity markets, capitalization and style. Companies are added and deleted from the various indices according to these changes. The Russell Microcap Index Fund had approximately $497 million of assets as of June 28, 2011.

New Energy Systems Group, through its subsidiaries, manufactures and distributes lithium battery shells and related products primarily in China.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Power3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Alzheimer’s disease is a type of brain disorder in which a person fails to follow his daily routine with full attentiveness. This disease usually appears in older people due to some genetic mutations that may cause building up of amyloidal proteins. This disease is less common in youth. If this disease runs into your family then any of the family members can show the symptoms as this disease is also a genetic disease.
Alzheimer’s disease is generally mistreated at early stages, because people and sometimes even doctors do not realize that the common symptoms like forgetfulness and losing track of things, vision problems and problem in hearing can be related to Alzheimer’s disease.

The NuroPro Test is currently in the development stages. The company has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

*********************************************

Aurizon Mines Ltd (AMEX:AZK) is pleased to announce that George N. Paspalas has agreed to join the Company as President and Chief Executive Officer and as a member of the Company’s Board of Directors, effective August 15, 2011. David Hall will continue as President & Chief Executive Officer until August 15, 2011 and, following Mr. Paspalas’s appointment, will continue to serve the Company as Chairman of the Board.

Aurizon Mines Ltd. engages in the acquisition, exploration, development, and operation of gold properties in North America.

*********************************************

Pioneer Drilling Co. (AMEX:PDC) announced that it has entered into an amendment and restatement of its existing credit agreement. The amended and restated credit agreement provides the Company with a $250 million, five-year, senior secured revolving credit facility. The amended and restated credit agreement, among other things: extends the maturity date of the credit agreement from August 31, 2012, to June 30, 2016; increases the aggregate amount of commitments under the credit agreement from $225 million to $250 million; improves the pricing terms for borrowings and the commitment fee; and provides the Company with increased flexibility under the financial covenants.

Pioneer Drilling Company, through its subsidiaries, provides contract land drilling services and production services to independent and major oil and gas exploration and production companies in the United States and Colombia.

*********************************************

Polymet Mining Corp. (AMEX:PLM) reported that: It has closed the previously-announced $4 million loan from Iron Range Resources & Rehabilitation Board (”IRRRB”), It has exercised its option to acquire two tracts of land totaling approximately 5,375 acres of forests, wetlands, and lakes with high recreational value that are included as part of the proposed land exchange with the U.S. Forest Service.

PolyMet Mining Corp., together with its subsidiary, Poly Met Mining, Inc., engages in the exploration, development, and acquisition of natural resource properties.

*********************************************

Rentech, Inc. (AMEX:RTK) announced its conference schedule for July 2011. July 26-27, 2011 U.S. Department of Energy Biomass 2011, Replace the Whole Barrel, Supply the Whole Market, National Harbor, MD. Attendees and exhibitors: Dan Cohrs, EVP & Chief Financial Officer and Harold Wright, Senior Vice President & Chief Technology Officer.

Rentech Inc. provides alternative and clean energy solutions; and manufactures and sells nitrogen fertilizer products.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

VirnetX Holding Corp (AMEX:VHC) announced that at the request of the Alliance for Telecommunications Industry Solutions (ATIS), it has agreed to update its licensing declaration to ATIS under ATIS’ Intellectual Property Rights (IPR) policy. This is in response to VirnetX’s March 14, 2011, Statement of Patent Holder identifying a group of its patents and patent applications that VirnetX believes are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. VirnetX will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) to 3GPP members desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under ATIS’ IPR policy.

VirnetX Holding Corporation engages in developing and commercializing software and technology solutions for securing real-time communications over the Internet.

*********************************************

Power3 Medical Products, Inc (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Breast cancer (breast) refers to the appearance of a malignant tumor in any part of the mammary gland. It is the second most common cancer in the world.

The growth and spread of breast cancer depends on the type of malignant cells that constitute it. If cancer is detected before it has spread to lymph or other body parts, the possibility of control is 90%, which means staying alive and without tumor five years after treatment.
The main signs and symptoms are:

A breast lump
Change the shape or contour of the breast
Collapse or crushing of the skin
Nipple retraction, or peeling
The breast looks red and swollen

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
Breast Cancer
Alzheimer’s Disease
ALS (Lou Gehrig’s Disease)
Parkinson’s Disease
Chemotherapeutic Drug Resistance
Leukemia
Gastrointestinal Disease
Metabolic Syndrome

For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com

*********************************************

Midway Gold Corp (AMEX:MDW) announced it has joined the U.S. broad-market Russell 3000® Index upon Russell Investments reconstituting its comprehensive set of U.S. and global equity indexes on June 24. Annual reconstitution of Russell’s U.S. indexes (www.russell.com/indexes) captures and ranks the 4,000 largest U.S. stocks as of the end of May by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Midway Gold Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in North America.

*********************************************

Palatin Technologies Inc. (AMEX:PTN) announced that Alan W. Dunton, M.D., has formally joined Palatin’s Board of Directors as an independent director and member of Palatin’s Audit and Compensation Committees. “Dr. Dunton brings Palatin both substantial drug development experience and clinical research experience,” said Carl Spana, Ph.D., Palatin’s CEO. “He has played a key role in the development of more than 20 products to regulatory approval. We look forward to working with him as a member of our Board of Directors.”

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States.

*********************************************

Quepasa Corp. (AMEX:QPSA) announced preliminary results from the launch of its first proprietary social gaming title, Cidade Maravilhosa - Rio, on Facebook. Quepasa highlighted that Cidade Maravilhosa has achieved over 150,000 installs in its first 10 full days on Facebook, with daily installs growing over 1,100% week over week as of June 28th.

Quepasa Corp., through its Web site, Quepasa.com, operates as an online social community for young Hispanics. Quepasa.com provides users with access to an expansive, multilingual menu of resources that promote social interaction, information sharing, and other topics of importance to Hispanic users.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Berkshire Hathaway Inc. (NYSE:BRK.A; BRK.B) reported the closing of the merger of Wesco Financial Corporation with and into a subsidiary of Berkshire Hathaway Inc.

********************

PWRM, Power3 Medical Products, Inc., PWRM.OB

Alzheimer’s is one, among the common sort of dementia, an over-all term regarding loss of memory and various other intellectual abilities serious enough to interfere with routine daily life. Alzheimer’s condition is the reason for 50 to seventy per cent of dementia cases.

As symptoms get worse, individuals with Parkinson’s disease may have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking.

Following skin cancer, cancers of the breast is a very general most cancers identified in women in north america.

PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

More about pWRM at www.power3medical.com.

********************

NHPR, National Health Partners, Inc., NHPR.OB

How much health insurance will cost you depends on your age, the condition of your health (how healthy or unhealthy you are), where in the country you live, your income, and your job status.

The uninsured pay more for care—and get less—than those with insurance. But when the uninsured cannot pay, health care providers shift those costs to those who can pay—those who have insurance coverage. This leads to higher premiums for those who buy their insurance on the individual market, as well as workers who get insurance for themselves and their families through their job.

The need for affordable healthcare alternatives has never been greater.

NHPR is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.”

NHPR recently reported the signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.

More about NHPR at www.nationalhealthpartners.com

********************

Pinnacle West Capital Corporation’s (NYSE:PNW) Board of Directors declared a quarterly dividend of $0.525 per share of common stock, payable on September 1, 2011, to shareholders of record on August 1, 2011.

********************

Allergan, Inc. (NYSE:AGN) reported the United States Food and Drug Administration (FDA) has approved a fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic.

The newly approved assay will be implemented immediately for release of product for sale in the United States. Allergan estimates that use of the new assay will reduce the use of animal-based assay testing for BOTOX® and BOTOX® Cosmetic by up to 95 percent or more over the next three years, as other regulatory agencies around the world approve this new assay.

The new assay is the first to be developed and approved for any botulinum neurotoxin currently available worldwide, and is specifically applicable to Allergan’s botulinum toxin type A product.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Power3 Medical Products, Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical Products, Inc. has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Breast cancer, which is highly treatable by surgery, radiation therapy, chemotherapy, and hormonal therapy, is most often curable when detected in early stages. Mammography is the most important screening modality for the early detection of breast cancer. Breast magnetic resonance imaging is under study as a diagnostic tool. Prognosis and selection of therapy are influenced by the age of the patient, stage of the disease, pathologic characteristics of the primary tumor including the presence of tumor necrosis, estrogen-receptor (ER) and progesterone-receptor (PR) levels in the tumor tissue, and measures of proliferative capacity, as well as by menopausal status and general health. Since criteria of menopausal status vary widely, age older than 50 years can be substituted as a definition of the postmenopausal state. Overweight patients may have a poorer prognosis. Prognosis may also vary by race, with blacks, and to a lesser extent Hispanics, having a poorer prognosis than whites. Breast cancer is classified into a variety of cell types, but only a few of these affect prognosis or selection of therapy. Rarely, the breast may be involved by other tumors such as melanoma, lymphoma, or sarcoma.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminates function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

For more information, please visit their website: http://www.power3medical.com

*********************************************************

Cleantech Transit Inc. (CLNO)

Most biomass is in solid form, but it can also be a liquid. Biomass usually consists of a complex polymer of carbon, hydrogen and oxygen with small amounts of nitrogen and inorganic elements. Biomass is not fossilized material (like oil, coal and gas) but fresh material that can grow again after having been harvested. Modern biomass is used to produce power and heat in large-scale facilities: solid biomass, biogas, biofuel or biodiesel.

Cleantech Transit Inc. recently announced that the previously announced 500 KW biomass gasification facility located in Merced, California has successfully passed its interconnection tests and is now connected to the utility distribution grid.

The gasification technology uses a non-combustion process to convert Ag and other woody residues into a hydrogen rich gas (”syngas”), which is then converted into electricity, along with heat and biochar (a useful byproduct that captures carbon in solid form and can be used as a soil amendment).

The Phoenix Energy technology used in Merced essentially cooks the biomass in an oxygen-deprived environment to release the elemental gasses from the wood. In the process biomass is converted into a carbon rich biochar. With the carbon fixed in solid form this process not only provides a valuable soil amendment but also serves as a source of carbon sequestration.

The Merced plant is expected to produce enough electricity to power about 400 homes. The plant connected to the electricity grid under California’s feed-in-tariff with a 15-year power purchase agreement.

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company’s manufacturing clients worldwide. Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.

Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.

*****************************************************

G&K Services Inc. (Nasdaq:GKSR) announced t that its Lion Uniform Group, recently received an “Image of the Year Award” from the National Association of Uniform Manufacturers and Distributors (NAUMD). These annual awards recognize distinctive image programs in the corporate uniform and apparel industry. This campaign adds to Lion Uniform Group’s growing list of “Image of the Year” awards, and is the seventh award received in the last three years.

G&K Services, Inc. provides branded identity apparel and facility services programs in North America. It offers rented uniforms and facility services products, such as floor mats, dust mops, wiping towels, restroom supplies, and various linen items.

*****************************************************

ascena retail group inc. (Nasdaq:ASNA) announced the release of its fiscal 2011 third quarter financial results on Wednesday, May 25, 2011. Results will be released over Business Wire at approximately 4:00 P.M. Eastern Time. The Company will also host a conference call at 4:30 P.M. Eastern Time to review its results, which will include comments by David R. Jaffe, President & CEO and Armand Correia, Executive Vice President & CFO followed by a question and answer session. Parties interested in participating in this call should dial in at (617) 213-8064 prior to the start time, the passcode is 90119640. The call will also be simultaneously broadcast at www.ascenaretail.com. A recording of the call will be available shortly after its conclusion and until June 25, 2011 by dialing (617) 801-6888, the passcode is 57765981.

ascena retail group inc. operates as a specialty retailer of apparel for women and tween girls in the United States and Puerto Rico. It operates its stores under the dressbarn, maurices, and Justice brand names.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (CLNO.OB).